Compare Dharma Samudera Fishing Industries Tbk. (DSFI) vs Hetzer Medical Indonesia Tbk. (MEDS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dharma Samudera Fishing Industries Tbk. vs Hetzer Medical Indonesia Tbk. — how do they compare? Dharma Samudera Fishing Industries Tbk. trades at Rp86 (market cap 137.43B, 54.09M 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp82 (market cap 126.56B, 289.5M 24h volume). The key difference: Dharma Samudera Fishing Industries Tbk. and Hetzer Medical Indonesia Tbk. are close in size by market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (289.5M versus 54.09M). Which is the better fit depends on your goals.
| DSFI | MEDS | |
|---|---|---|
Market Cap | 137.43B | 126.56B |
Volume | 54.09M | 289.5M |
Lot | 540.9K | 2.9M |
Turnover | 4.56B | 24.93B |
Average Price | 84.31 | 86.12 |
Value | 4.56B | 24.93B |
Indicative Equilibrium Price | 74 | 84 |
Indicative Equilibrium Volume | 14.6K | 22.76K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dharma Samudera Fishing Industries Tbk.
PT Dharma Samudera Fishing Industries Tbk (the Company) was established in Jakarta on October 2, 1973. Since its operation in 1983 in Kendari – South-east Sulawesi, the Company acts as a processor who depends on the supply from fishermen and by coordination of the company. Currently, the Company is one of the largest processing companies in Indonesia for frozen fish product which the market share in 1998 reached 69,69% for frozen fish fillet and 71,43% for frozen lobster . While for red snapper fillet, the Company has a 70% market share in USA and 50% market share in Japan.
Read more on DSFI →About Hetzer Medical Indonesia Tbk.
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →
